H1N1 Neuraminidase Antibody |
24923 |
SAB |
100ul |
EUR 479 |
Human IgG antibody Laboratories manufactures the influenza a h1n1 neuraminidase antibody sino reagents distributed by Genprice. The Influenza A H1N1 Neuraminidase Antibody Sino reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact influenza Antibody. Other Influenza products are available in stock. Specificity: Influenza Category: A Group: H1N1 Neuraminidase
Seasonal H1N1 Neuraminidase Antibody |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Seasonal H1N1 Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups. |
Swine H1N1 Neuraminidase Antibody |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: Swine H1N1 Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups. |
Swine H1N1 Neuraminidase Antibody |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Swine H1N1 Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups. |
H1N1 Neuraminidase Peptide |
ProSci |
0.05 mg |
EUR 197.7 |
Description: H1N1 Neuraminidase peptide |
Seasonal H1N1 Neuraminidase Monoclonal Antibody |
SAB |
100ul |
EUR 479 |
Seasonal H1N1 Neuraminidase Monoclonal Antibody |
SAB |
100ul |
EUR 468 |
Seasonal H1N1 Neuraminidase Monoclonal Antibody |
SAB |
100ul |
EUR 479 |
H1N1 Neuraminidase information
Influenza A [A/Victoria/4897/2022(H1N1)] Neuraminidase (NA) Protein, His Tag |
NEE-V524c |
ACROBIOSYSTEMS |
1mg |
EUR 374.5 |
|
Description: Influenza A [A/Victoria/4897/2022(H1N1)] Neuraminidase (NA) Protein, His Tag (NEE-V524c) is expressed from human 293 cells (HEK293). It contains AA Val 80 - Asn 469 (Accession # EPI_ISL_17102775, GISAID). |
Influenza A [A/Victoria/4897/2022 (H1N1)] Neuraminidase (NA) Protein, His Tag |
NEE-V55H5 |
ACROBIOSYSTEMS |
1mg |
EUR 374.5 |
|
Description: Influenza A [A/Victoria/4897/2022 (H1N1)] Neuraminidase (NA) Protein, His Tag (NEE-V55H5) is expressed from Baculovirus-Insect cells. It contains AA Ile 30 - Asn 469 (Accession # EPI_ISL_17102775, GISAID). |
Influenza A [A/swine/Shandong/1207/2016 (H1N1)] Neuraminidase (NA), His-Tag |
REC31893-100 |
The Native Antigen Company |
0.1 |
EUR 355.94 |
Description: Swine influenza A virus Shandong/1207/2016 neuraminidase protein produced in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography. This virus strain is commonly called G4 reassortant, and contains genes from the 2009 influenza pandemic strain, and bird and pig influenza virus strains. There is evidence that this strain replaced other influenza viruses circulating in pigs in Chinese swine works, and a danger that this strain will become pandemic. |
Influenza A [A/swine/Shandong/1207/2016 (H1N1)] Neuraminidase (NA), His-Tag |
REC31893-500 |
The Native Antigen Company |
0.5 |
EUR 1247.68 |
Description: Swine influenza A virus Shandong/1207/2016 neuraminidase protein produced in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography. This virus strain is commonly called G4 reassortant, and contains genes from the 2009 influenza pandemic strain, and bird and pig influenza virus strains. There is evidence that this strain replaced other influenza viruses circulating in pigs in Chinese swine works, and a danger that this strain will become pandemic. |
Influenza A Neuraminidase N1 Antibody |
GWB-73EE7F |
GenWay Biotech |
0.1 mg |
Ask for price |
Influenza A [Victoria/2570/2019(H1N1)] Neuraminidase (NA) Protein, His Tag |
NEE-V524e |
ACROBIOSYSTEMS |
1mg |
EUR 374.5 |
|
Description: Influenza A [Victoria/2570/2019(H1N1)] Neuraminidase (NA) Protein, His Tag (NEE-V524e) is expressed from human 293 cells (HEK293). It contains AA Val 80 - Lys 469 (Accession # EPI_ISL_417210, GISAID). |
Influenza A [Wisconsin/588/2019(H1N1)] Neuraminidase (NA) Protein, His Tag |
NEE-V524k |
ACROBIOSYSTEMS |
1mg |
EUR 374.5 |
|
Description: Influenza A [Wisconsin/588/2019(H1N1)] Neuraminidase (NA) Protein, His Tag (NEE-V524k) is expressed from human 293 cells (HEK293). It contains AA Val 80 - Lys 469 (Accession # EPI_ISL_404527, GISAID). |
OAPB01907-100UG - Avian Influenza A H7N9 Neuraminidase Antibody - N-terminal |
OAPB01907-100UG |
Aviva Systems Biology |
100ug |
EUR 389 |
|
OAPB01908-100UG - Avian Influenza A H7N9 Neuraminidase Antibody - N-terminal |
OAPB01908-100UG |
Aviva Systems Biology |
100ug |
EUR 389 |
|
Influenza B Neuraminidase Antibody |
abx022025-05mg |
Abbexa |
0.5 mg |
EUR 1312.8 |
|
Influenza B Neuraminidase Antibody |
abx022026-05mg |
Abbexa |
0.5 mg |
EUR 1378.8 |
|
Influenza B Neuraminidase Antibody |
abx022027-05mg |
Abbexa |
0.5 mg |
EUR 1378.8 |
|
Influenza B Neuraminidase Antibody |
GWB-6F44A8 |
GenWay Biotech |
0.5 mg |
Ask for price |
Influenza B Neuraminidase Antibody |
GWB-F47D6E |
GenWay Biotech |
0.5 mg |
Ask for price |